Clinical Trial Update: Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating Endostar in combination with cisplatin and capecitabine as first-line therapy for advanced gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Endostar (recombinant human endostatin)

Snippet

Sponsor: Peking University | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED